SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-023589
Filing Date
2021-02-01
Accepted
2021-02-01 06:32:01
Documents
14
Period of Report
2021-01-29
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d113354d8k.htm   iXBRL 8-K 27412
2 EX-99.1 d113354dex991.htm EX-99.1 10208
6 GRAPHIC g113354ig1.jpg GRAPHIC 11360
  Complete submission text file 0001193125-21-023589.txt   183978

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mnov-20210129.xsd EX-101.SCH 3074
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnov-20210129_lab.xml EX-101.LAB 18906
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnov-20210129_pre.xml EX-101.PRE 11865
7 EXTRACTED XBRL INSTANCE DOCUMENT d113354d8k_htm.xml XML 3514
Mailing Address 4275 EXECUTIVE SQUARE SUITE 300 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE SUITE 300 LA JOLLA CA 92037 858-373-1500
MEDICINOVA INC (Filer) CIK: 0001226616 (see all company filings)

IRS No.: 330927979 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33185 | Film No.: 21574245
SIC: 2834 Pharmaceutical Preparations